285 related articles for article (PubMed ID: 11824861)
1. A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes.
Bakris G; Sica D; Ram V; Fagan T; Vaitkus PT; Anders RJ
Am J Hypertens; 2002 Jan; 15(1 Pt 1):53-7. PubMed ID: 11824861
[TBL] [Abstract][Full Text] [Related]
2. Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising.
White WB; Sica DA; Calhoun D; Mansoor GA; Anders RJ
Am Heart J; 2002 Oct; 144(4):657-65. PubMed ID: 12360162
[TBL] [Abstract][Full Text] [Related]
3. Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product.
White WB; Black HR; Weber MA; Elliott WJ; Bryzinski B; Fakouhi TD
Am J Cardiol; 1998 Feb; 81(4):424-31. PubMed ID: 9485131
[TBL] [Abstract][Full Text] [Related]
4. Gender and age effects on the ambulatory blood pressure and heart rate responses to antihypertensive therapy.
White WB; Johnson MF; Black HR; Elliott WJ; Sica DA
Am J Hypertens; 2001 Dec; 14(12):1239-47. PubMed ID: 11775133
[TBL] [Abstract][Full Text] [Related]
5. Effects of controlled-onset extended-release verapamil on nocturnal blood pressure (dippers versus nondippers). COER-Verapamil Study Group.
White WB; Mehrotra DV; Black HR; Fakouhi TD
Am J Cardiol; 1997 Aug; 80(4):469-74. PubMed ID: 9285660
[TBL] [Abstract][Full Text] [Related]
6. Novel delivery system for verapamil designed to achieve maximal blood pressure control during the early morning.
Neutel JM; Alderman M; Anders RJ; Weber MA
Am Heart J; 1996 Dec; 132(6):1202-6. PubMed ID: 8969572
[TBL] [Abstract][Full Text] [Related]
7. Effects of the chronotherapeutic delivery of verapamil on circadian blood pressure in African-American patients with hypertension.
White WB; Johnson MF; Black HR; Fakouhi TD
Ethn Dis; 1999; 9(3):341-9. PubMed ID: 10600056
[TBL] [Abstract][Full Text] [Related]
8. Effects of COER-verapamil on circadian pattern of forearm vascular resistance and blood pressure.
Nguyen BN; Parker RB; Noujedehi M; Sullivan JM; Johnson JA
J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1480-7. PubMed ID: 11185670
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate.
White WB; Mansoor GA; Pickering TG; Vidt DG; Hutchinson HG; Johnson RB; Noveck R
Am J Hypertens; 1999 Aug; 12(8 Pt 1):806-14. PubMed ID: 10480474
[TBL] [Abstract][Full Text] [Related]
10. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
White WB; Lacourciere Y; Gana T; Pascual MG; Smith DH; Albert KS
Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
[TBL] [Abstract][Full Text] [Related]
12. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
White WB; Lacourciere Y; Davidai G
Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators.
Lacourcière Y; Asmar R
Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1181-7. PubMed ID: 10619580
[TBL] [Abstract][Full Text] [Related]
14. A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension.
Fagard R; Lijnen P; Pardaens K; Thijs L; Vinck W
J Hum Hypertens; 2001 Mar; 15(3):161-7. PubMed ID: 11317199
[TBL] [Abstract][Full Text] [Related]
15. Circadian heart rate response to chronotherapy versus conventional therapy in patients with hypertension and myocardial ischemia.
Glasser SP; Frishman W; White WB; Stone P; Johnson MF
Clin Cardiol; 2000 Jul; 23(7):524-9. PubMed ID: 10894441
[TBL] [Abstract][Full Text] [Related]
16. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
[TBL] [Abstract][Full Text] [Related]
17. Chronotherapeutic delivery of verapamil in obese versus non-obese patients with essential hypertension.
White WB; Elliott WJ; Johnson MF; Black HR
J Hum Hypertens; 2001 Feb; 15(2):135-41. PubMed ID: 11317194
[TBL] [Abstract][Full Text] [Related]
18. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
[TBL] [Abstract][Full Text] [Related]
19. Optimizing delivery systems to tailor pharmacotherapy to cardiovascular circadian events.
Carter BL
Am J Health Syst Pharm; 1998 Nov; 55 Suppl 3():S17-23. PubMed ID: 9825045
[TBL] [Abstract][Full Text] [Related]
20. Comparison of labetalol versus enalapril as monotherapy in elderly patients with hypertension: results of 24-hour ambulatory blood pressure monitoring.
Applegate WB; Borhani N; DeQuattro V; Kaihlanen PM; Oishi S; Due DL; Sirgo MA
Am J Med; 1991 Feb; 90(2):198-205. PubMed ID: 1996588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
